Delivery Order SPE2DB22D2211-SPE2DB25FRUWY
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Albumin (Human) 25% IV Solution, 50 mL, a critical medical product used in healthcare settings. The contract has a firm fixed price and a ceiling value of $1,040.20, with a period of performance through May 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albumin (Human) 25% IV Solution 50 mL, a medical product used in healthcare settings. The award has a ceiling value of $1,560.30 and a period of performance through July 15, 2025. This order is not associated with a set-aside designation, indicating open competition....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,080.40 and covers the delivery of albumin (human) 25% IV solution in 50 ml containers. This order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of albumin (human) 25% intravenous solution in 50 ml vials, with a ceiling value of $1,005.20 and a period of performance through July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albumin (Human) 5% IV Solution 250ML, a medical product, with a ceiling value of $2,511.60 and a completion date of June 10, 2025. The contract is firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albumin (Human) 5% IV Solution 250ML. The contract has a ceiling value of $2,511.60 and a performance period ending on July 28, 2025. The contract is not set aside and was awarded on July 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albumin (Human) 5% IV Solution 250ML, a critical medical product. The contract has a ceiling value of $1,255.80 and is a firm fixed price contract type. The place of performance is Conshohocken, PA. The contract is not set aside and is an open competition award. AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,614,514 units of Albumin (Human) 25% IV Solution 50 mL, a critical medical product, with a ceiling value of $5,439.72. The contract has a completion date of September 19, 2024 and was awarded on August 28, 2024 through a non-set-aside procurement. AmerisourceBergen is a major supplier of...
- This is a $1,668.10 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ALBUMIN (HUMAN) 25% IV SOLN 50ML. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. This delivery order is part of a larger...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,511.60, is for the supply of Albumin (Human) 5% IV Solution 250ML. The contract has an ultimate completion date of April 2, 2025 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRUWYDelivery Order
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albumin (Human) 25% IV Solution 100 mL, a medical product, with a ceiling value of $2,080.20 and a period of performance through April 29, 2025. The contract is a firm fixed-price, non-set-aside delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely one of many under the larger IDC contract, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 4/8/25 |